Ulcerative colitis is a chronic inflammatory disease of the large intestine (colon) in which the immune system attacks the colon’s inner lining, causing open sores, bleeding, and digestive symptoms that can range from mild to debilitating. It belongs to the family of inflammatory bowel diseases alongside Crohn’s disease, and it affects people worldwide, with rising incidence rates globally.
What Happens Inside the Colon
In a healthy colon, a thin layer of mucus and tightly packed cells form a barrier that keeps bacteria and waste from touching deeper tissue. In ulcerative colitis, that barrier breaks down. Defects in the mucus layer and the cells lining the colon (colonocytes) allow gut bacteria to come into direct contact with intestinal tissue, triggering an immune reaction that never fully shuts off.
The inflammation is driven by both branches of the immune system. Certain immune cells produce signaling molecules that damage the colon’s surface cells and prevent them from healing. Neutrophils, a type of white blood cell, flood into the colon wall during active disease. Meanwhile, specialized immune cells called dendritic cells ramp up their activity, perpetuating the cycle. The result is continuous inflammation confined to the innermost lining of the colon, unlike Crohn’s disease, which can affect deeper layers of the intestinal wall and occur anywhere in the digestive tract.
One critical difference: ulcerative colitis always starts in the rectum and spreads upward in an unbroken pattern. There are no “skip areas” of healthy tissue between inflamed segments, which helps doctors distinguish it from Crohn’s disease during examination.
Types Based on How Far It Spreads
Doctors classify ulcerative colitis by how much of the colon is involved:
- Proctitis (E1): Inflammation limited to the rectum. This is often the mildest form and can sometimes be managed with medications applied directly to the area.
- Left-sided colitis (E2): Inflammation extends from the rectum up through the left side of the colon, roughly to the bend near the spleen.
- Pancolitis (E3): The entire colon is inflamed. This form carries the highest risk of complications and is more likely to require aggressive treatment.
The disease can progress from one category to another over time. Someone diagnosed with proctitis may eventually develop left-sided or pan-colonic disease, which is one reason ongoing monitoring matters.
Common Symptoms
The hallmark symptoms are bloody diarrhea and an urgent, sometimes uncontrollable need to use the bathroom. During a flare, you might experience frequent loose stools mixed with blood or mucus, cramping abdominal pain (usually on the left side), and a feeling that your bowels haven’t fully emptied even right after going. Fatigue is extremely common and often underestimated.
Severity varies widely. Some people have a few extra bowel movements per day with minimal blood. Others may go 10 or more times daily, lose significant amounts of blood, and develop fever, rapid heart rate, or weight loss. Doctors use scoring systems that factor in stool frequency, rectal bleeding, and the endoscopic appearance of the colon to gauge disease activity on a scale from remission to severe.
Ulcerative colitis also causes problems outside the gut in some people, including joint pain, skin rashes, eye inflammation, and liver conditions. These “extraintestinal” manifestations can sometimes appear before bowel symptoms do.
What Causes It
There is no single cause. Ulcerative colitis develops from a combination of genetic susceptibility, immune dysfunction, environmental triggers, and shifts in gut bacteria. Researchers have identified variations in dozens of genes linked to the disease, many of which are involved in maintaining the intestinal barrier or regulating T cells, the immune cells that coordinate the body’s inflammatory response.
The prevailing theory is that genetically susceptible people experience a breakdown in the colon’s protective barrier, allowing normal gut bacteria to trigger an immune overreaction that becomes self-sustaining. Environmental factors likely play a role in flipping the switch: the disease is more common in industrialized countries, and its incidence is rising in regions that are adopting Western diets and lifestyles. While ulcerative colitis predominantly affects adolescents and young adults, it can be diagnosed at any age.
How It’s Diagnosed
A colonoscopy with biopsies is the standard way to confirm ulcerative colitis. During the procedure, doctors look for a distinct pattern: continuous inflammation starting at the rectum and extending upward without gaps. The inflamed lining typically appears grainy, bleeds easily when touched, and loses the normal blood vessel pattern visible in healthy tissue. In more severe cases, deep ulcers and spontaneous bleeding are visible.
Tissue samples taken during the colonoscopy reveal specific microscopic changes. Active disease shows neutrophils invading the glands of the colon lining, forming small pockets of pus called crypt abscesses. Signs of chronic, ongoing damage include distorted gland architecture and an increase in certain immune cells in the tissue. These features of chronicity help doctors rule out a temporary bacterial infection, which can look similar on the surface but doesn’t cause the same lasting structural changes.
In about 25% of people with pancolitis, mild inflammation spills into the very end of the small intestine, a finding called backwash ileitis. This can occasionally cause confusion with Crohn’s disease, but it appears as a short, continuous segment without the narrowing or deep ulcers typical of Crohn’s.
Treatment Approaches
Treatment aims to stop active inflammation (inducing remission) and then keep it from coming back (maintaining remission). The specific approach depends on how much of the colon is affected and how severe the inflammation is.
For mild to moderate disease, anti-inflammatory medications that target the colon lining directly are the first step. These come as oral pills, enemas, or suppositories, and the rectal forms work well for disease confined to the lower colon and rectum. When inflammation is more widespread or doesn’t respond to these, doctors may add medications that suppress the overactive immune response more broadly. Short courses of corticosteroids can bring flares under control quickly but aren’t safe for long-term use due to side effects like bone thinning and increased infection risk.
For moderate to severe disease that doesn’t respond to conventional treatments, biologic therapies and newer oral medications called JAK inhibitors have expanded the options significantly. Biologics are given by injection or infusion and work by blocking specific immune signaling molecules that drive inflammation. JAK inhibitors, approved for ulcerative colitis starting in 2018, are oral pills that interrupt inflammatory pathways inside immune cells. These advanced therapies have reduced the need for surgery in many patients who previously had few options.
Despite these advances, roughly 10 to 15% of people with ulcerative colitis will need surgery at some point. The most common procedure removes the entire colon and rectum, then creates an internal pouch from the end of the small intestine that connects to the anus, restoring the ability to have bowel movements without a permanent external bag. This is typically done in stages, with the pouch constructed three to six months after the initial colon removal.
Diet During Flares and Remission
Diet doesn’t cause ulcerative colitis, but what you eat can influence symptoms and potentially help maintain remission. The evidence points to different strategies depending on whether you’re in a flare or feeling well.
During active flares, plant-based diets combined with standard medical therapy have shown promising results, with one study reporting a 76% remission rate. Eating omega-3 rich fish like salmon (about 600 grams per week in one study) reduced symptom scores in people with mild disease. Extra-virgin olive oil also lowered inflammatory markers and improved gut symptoms compared to other cooking oils.
During remission, the goal shifts to preventing relapse. Anti-inflammatory diets emphasizing fruits, vegetables, and whole grains while limiting red meat, processed foods, and dairy have been associated with lower relapse rates and better quality of life. For people who experience lingering digestive discomfort even when inflammation is controlled, a low-FODMAP diet (which restricts certain fermentable carbohydrates) has helped a higher proportion of patients find symptom relief. One study found that a low-FODMAP approach also reduced markers of inflammation and improved the balance of gut bacteria in people with quiescent ulcerative colitis.
Colorectal Cancer Risk Over Time
The longer ulcerative colitis persists, the higher the risk of developing colorectal cancer. The most widely cited estimates put the cumulative risk at about 2% after 10 years of disease, 8% after 20 years, and 18% after 30 years. Beyond 30 years, the annual risk rises even more steeply. The two biggest factors driving this risk are disease duration and how much of the colon is involved, with pancolitis carrying the highest risk.
This is why surveillance colonoscopies become routine after the first 8 to 10 years of disease. These exams look for precancerous cellular changes called dysplasia, which can be treated or trigger a recommendation for colon removal before cancer develops. Population-based studies from some countries have found lower cancer rates than the older estimates suggest, likely reflecting better disease control with modern treatments and more consistent surveillance programs.